We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Diagnostic Microarray Characterizes Supernumary Chromosomes

By HospiMedica staff writers
Posted on 08 Nov 2006
A microarray has been developed that can rapidly characterize supernumary or marker chromosomes. More...
The information obtained from using this cytogenetic tool should lead to improved diagnosis and management of patients with marker chromosomes. In addition, high-resolution characterization of marker chromosomes will expand scientific knowledge of pericentromeric regions.

A diagnostic microarray for characterizing supernumerary marker chromosomes was constructed with over 900 bacterial artificial chromosome (BAC) clones, and represents, on average, more than 5.3 MB of each of the 43 unique pericentromeric regions of the human genome. Thus, the chromosomal origin of a marker can be determined together with the amount of euchromatin present.

The Signature MarkerChip, a diagnostic microarray for marker chromosomes, was developed by Signature Genomic Laboratories, LLC (Spokane, WA, USA). The chip is designed to analyze only the pericentromeric regions of the chromosomes to characterize marker chromosomes previously identified by chromosome analysis. The SignatureChip evaluates multiple areas of the genome for unbalanced microscopic and submicroscopic deletions and duplications.

A supernumary chromosome is a small chromosome containing a centromere occasionally seen in tissue culture, often in a mosaic state (present in some cells but not in others). A marker chromosome may be of little clinical significance or, if it contains material from one or both arms of another chromosome, may create an imbalance for whatever genes are present; assessment to establish the clinical significance, particularly if found in a fetal karyotype, is often difficult.

Clinicians are often required to use labor-intensive approaches to determine the origin and euchromatic content of a marker because traditional cytogenetic analysis is not always sufficient. Signature Genomic Laboratories recognized the need for a cytogenetic tool that could rapidly characterize marker chromosomes. Clinicians and cytogenetic laboratories can order the Signature MarkerChip whenever karyotype, fluorescent in situ hybridization (FISH), or general microarray analysis identifies a marker chromosome in an individual or a pregnancy.

If a marker chromosome does not contain euchromatin, the Signature MarkerChip will not detect the marker. In addition, low levels of mosaicism may not be detected by array comparative genomic hybridization (CGH).



Related Links:
Signature Genomic Laboratories

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Gold Member
Electrode Solution and Skin Prep
Signaspray
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.